FDA NDC Directory · JSON-LD · Markdown

Dexlansoprazole

NDC 0378-2086 · HUMAN PRESCRIPTION DRUG · CAPSULE, DELAYED RELEASE PELLETS

Generic namedexlansoprazole
Labeler / ManufacturerMylan Pharmaceuticals Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA205205
Dosage form / routeCAPSULE, DELAYED RELEASE PELLETS · ORAL
Active ingredientsDEXLANSOPRAZOLE SESQUIHYDRATE (60 mg/1)
Marketing started20240122
Package count2

External sources

Source: openFDA. Public-domain (CC0).